A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/506 (2006.01) A61K 31/195 (2006.01) A61K 31/5377 (2006.01) A61P 11/08 (2006.01)
Patent
CA 2624716
The present invention relates to the use of compounds of formulae I-VI for producing a drug for treating acute and chronic lung diseases, such as Respiratory Distress Syndrome [acute lung injury (ALI), acute respiratory distress syndrome (ARDS)], and for treating COPD.
L'invention concerne l'utilisation de composés de formules I à VI destinés dans la production d'un médicament destiné à traiter des maladies pulmonaires aiguës et chroniques, telles que le syndrome de détresse respiratoire (ALI), le syndrome de détresse respiratoire aigu (SDRA), ainsi qu'à traiter la maladie pulmonaire obstructive chronique (MPOC).
Krahn Thomas
Stasch Johannes-Peter
Thielemann Wolfgang
Weimann Gerrit
Bayer Healthcare Ag
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Use of soluble guanylate cyclase activators for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of soluble guanylate cyclase activators for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of soluble guanylate cyclase activators for treating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1698522